Technical / White Paper
Scalability, Quality, and Speed with Transposons
To solve for the significant bottlenecks often presented by conventional cell line development processes, this article discusses how Wheeler Bio is leveraging transposon-based gene delivery to compress timelines, increase clone stability, and offer uncompromising titers. As an integral enabler of our innovative Portable CMC™ Clone Selection service, this cutting-edge approach is a key differentiator to our CLD services.
